Treating COVID-19—Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics
University of Nebraska Medical Center
Indexed incrossrefpubmed
Abstract
Chenguang Shen, PhD; Zhaoqin Wang, PhD; Fang Zhao, PhD; Yang Yang, MD; Jinxiu Li, MD; Jing Yuan, MD; Fuxiang Wang, MD; Delin Li, PhD; Minghui Yang, PhD; Li Xing, MM; Jinli Wei, MM; Haixia Xiao, PhD; Yan Yang, MM; Jiuxin Qu, MD; Ling Qing, MM; Li Chen, MD; Zhixiang Xu, MM; Ling Peng, MM; Yanjie Li, MM; Haixia Zheng, MM; Feng Chen, MM; Kun Huang, MM; Yujing Jiang, MM; Dongjing Liu, MD; Zheng Zhang, MD; Yingxia Liu, MD; Lei Liu, MD
Citation impact
520
total citations
- FWCI
- 163.00
- Percentile
- 100%
- References
- 8
Citations per year
Authors
1Topics & keywords
Topics
Keywords
- Medicine
- Coronavirus disease 2019 (COVID-19)
- Zhàng
- Pandemic
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- 2019-20 coronavirus outbreak
- Virology
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.